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The CYPZBIIZ gene pair is an example of many liver genes that exhibit a characteristic zonated expression pattern in the liver. The factors governing 
this zonatton are poorly understood. We observed that after hypophysectomy the expression of CYP2B1/2 protein and mRNA in the normally 
silent periportal (upstream) region was high, m both male and female rats. Treatment with growth hormone counteracted the effect of hypophys- 
ectomy, limiting expression to the perivenous (downstream) regton, completely in females and partially m males. This shows that a hormone 
zone-specifically regulates gene expression in the liver. 
Hypophysectomy: Rat: Growth hormone; Cytochrome P450 expression; Liver zonation; Perivenous 
1. INTRODUCTION 
The mechanisms responsible for the spatial pattern of 
gene expression in different organs are not well under- 
stood. In the mature mammalian liver the majority of 
the genes investigated so far have been observed to 
exhibit a zonated expression pattern within the acinus, 
the microcirculatory unit of the liver [1,2]. Blood- 
bourne factors, including oxygen, nutrients, and 
hormones, all of which form gradients as a result of the 
unidirectional blood flow, have been suggested to be 
responsible for establishment of this zonation. How- 
ever, the possible role of specific hormones has to date 
received little attention. Members of the cytochrome 
P450 (C YP)* gene superfamily serve as good models to 
address this question, since the expression of most of 
these genes seems to be particularly zonated, their ex- 
pression being restricted to the perivenous (centrilobu- 
lar) region [3-51. In addition, the expression of several 
members of the CYP family has been found to be regu- 
lated by pituitary-dependent hormones. Thus the etha- 
nol-inducible CYP2El is increased by hypophysectomy 
and decreased by treatment with growth hormone (GH) 
[6]. The expression of the male-specific CYP2Cll form 
is stimulated by the male-type episodic GH secretion [7] 
but suppressed by the female-type more continuous GH 
secretion, which in turn leads to stimulation of the fe- 
male-specific CYPZC12 expression [8]. We studied the 
expression of the phenobarbital-inducible CYP2B112 
gene pair which is also increased by hypophysectomy. 
decreased by growth hormone [9], and constitutively 
expressed in the perivenous region [lo]. We hypothe- 
sized that growth hormone may affect not only the over- 
all expression of CYP2B1/2 but also regulate the acinar 
distribution. We studied the effect of hypophysectomy 
and of GH administration on zonation both by immu- 
nohistochemistry and by analysis of periportal and peri- 
venous cell lysates. The lysates were obtained by a zone- 
restricted digitonin pulse during in situ liver perfusion 
and analysed for their content of CYP2B1/2 apoprotein 
and mRNA by immunoblotting and by reverse tran- 
scription of RNA followed by PCR analysis [l 11. Hypo- 
physectomy was found to permit and GH treatment to 
prevent the expression of CYP2B1/2 in the periportal 
region, suggesting that the regulation of CYP2B1/2 ex- 
pression by GH is zone-specific. 
2. EXPERIMENTAL 
2.1. Ammals 
Correspondence address. K.O. Lindros, Biomedical Research Center, 
Alko Ltd, PO Box 350, 00101 Helsinki, Finland. Fax: (358) (0) 133 
2781. 
*The nomenclature for cytochrome P450 proposed by Nebert et al. in 
(1991) DNA Cell Biol. 10, l-14. is used. 
Abbreviations: EGF, eprdermal growth factor; GH, growth hormone: 
hGH, human recombinant growth hormone. 
Hypophysectomized and sham operated male and female Sprague- 
Dawley rats were obtained from Mollegaard, Ejby, Denmark. The 
animals were hypophysectomrzed at the age of 5 weeks. transferred to 
our laboratory at the age of 6 weeks, and were then allowed to stabilize 
for 1 week. All animals were fed a commercial R3 laboratory diet 
(Ewos. Siidertalje, Sweden) and water ad libitum. The hypophysecto- 
mrzed rats were given human recombmant growth hormone (hGH; 
Nordttropin, Nordisk Gentofte A/S, Denmark), 0.01 IU/h. or salme 
by continuous mfuston for 7 days. For the continuous GH mfusion, 
osmotic mmtpumps (Alzet 1701, Palo Alto, CA. USA) were Implanted 
subcutaneously on the backs under halothane anesthesta. The effect 
of GH treatment was monitored as weight Increase. The experiments 
were approved by the local committe for animal experiments. 
2.2. Immunohrstochemrcul locallxztlon of CYPZBll2 
Liver tissue was fixed. sectioned and treated as prevtously described 
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[5]. The rabbit anttserum against rat CYPZBlQ and the purtfied pro- 
tein were generously donated by Dr. Magnus Ingelman-Sundberg. 
2.3. Collectron of perlportcrl and pcr(vcnorrs cell iJ~.sates 
Zone-spectfic cell lysis was achteved durmg m sttu perfuston by a 
modtfied dual digitonm pulse technique [12]. Briefly, pertportal cells 
were lysed by infusing 6.7 ml/kg b.wt. of 3.5 mM dtgitonm (ICN, 
Cleveland, OH. USA) vta the portal vem, and the lysate was collected 
by immedtate retrograde tlushmg. Perivenous cell lysates were ob- 
tained by infusmg 10 ml/kg b.wt. digttonm solutton vta the upper vena 
cava followed by antegrade flushing. The zone-specifictty of the cell 
lysates was verified by alanine ammotransferase (ALAT. EC 2.6.1.2.) 
assay as tn [13]. 
Cell lysate proteins (30 or 60 pg) were separated in 8.7% SDS- 
polyacrylamtde gels and transferred electrophorettcally to mtrocellu- 
lose filters. The filters were blocked wtth bovine serum albumin and 
probed with rabbtt polyclonal IgG to rat CYP2BlI2 (Oxygen. Dallas, 
TX, USA). Bands were stamed wtth ProtoBlot AP system (Promega. 
Madison, WI. USA) and assayed using a UVP GDS 2000 videoden- 
sttometer (Ultravtolet Products, Cambrtdge, UK) and purified 
CYP2Bl/2 as Internal standard. The lmeartty of the response wtthm 
the protein range used was checked. 
Total RNA from 0.5 ml of digttomn eluates (which are vtrtually 
devoid of nuclear maternal) was Isolated as described by Chomczynski 
and Saccht [14] except that 0.25 ml of both phenol and chloroform was 
used and extractton was performed twtce with phenol/chloroform and 
once with 0.5 ml of chloroform. The amount of RNA was determmed 
spectrophotometrically at 260 nm. purtty by nucletc acrd/protein ratto 
(A2,,jA,,,,). and mtegrtty by RNA electrophoresis m 2.2 M formalde- 
hyde/l 25% agarose gels First strand cDNA was produced from 2 pg 
RNA m an 80 ~1 reactton volume usmg Promega’s Reverse Transcrip- 
tton System and random hexanucleotlde primers. The response was 
linear under the condtttons used. 
Thts was performed using a PCR-based semtquantitattve method 
[ll]. For PCR of cDNA from reverse-transcrtbed RNA. we used 
primers specific to both tsozyme forms: 5’.CCA TGA CCC ACA 
GTA CTT TGA CC-3’ (sense) and S’TGC CAC TCT CCT TGG 
GCG TG-3’ (anttsense) Primers were from exons 8 and 9, and PCR 
produced an expected 242 bp fragment lo@ of cDNA was amplified 
m 100 ~1 reaction volume contammg 2 LJ 7hq DNA polymerase. 
1 x PCR buffer (both from Promega). 50 pmol of both primers, 
0.2 PM each dNTP. and 2 mM MgCl?. Amplification in the programma- 
ble thermal controller (MJ Research. Inc. Watertown. MA. USA) 
consisted of 30 cycles at 95°C for 1 min. 55°C for 1 mm, 72°C for 
1 mm. In the last cycle the elongation step was extended to 5 mm. 
20 ~1 of amplification product was run in 4% NuSteve GTG (FMC 
BioProducts. Rockland. ME, USA) agarose gel electrophoresis. Gels 
were stained with ethtdium bromide, video photographed under UV 
illummation, and video scanned as tmmunoblots. The curvilineartty 
of amplification was vahdated by varying the amount of cDNA and 
number of cycles Samples to be compared were always run together, 
The wtthm-assay reproductbility of the reverse transcrtption reaction 
and of PCR amplification were 100 ?I 7 (n = 16) and 100 ? 16 (II = 20) 
(mean ?I S D.). 
3. RESULTS AND DISCUSSION 
Immunohistochemical examination of liver sections 
revealed that CYP2BlR staining, normally restricted to 
the perivenous region, was markedly changed after hy- 
pophysectomy. In the liver of female rats, CYPZBl/2 
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staining had spread towards the terminal portal veins, 
leaving only the most aflluent areas unstained (Fig. 1). 
Hypophysectomized male animals exhibited corre- 
sponding changes in their distribution pattern. 
The most conspicuous effect of hypophysectomy on 
the acinar distribution of CYP2B1/2 protein was seen 
by comparing the periportal and perivenous cell lysates. 
In periportal samples from control females, no 
CYP2B1/2 protein could be detected and in males only 
a faint band was seen (Fig. 2). In marked contrast. after 
hypophysectomy, the amount of CYP2B1/2 protein in 
periportal samples had increased at least 50-fold (Fig. 
3), to the same level as in perivenous lysates. The same 
effect was seen in males. Semiquantitative determina- 
tion of CYP2Bl and 2B2 mRNA revealed that the aci- 
nar distribution and the effect of hypophysectomy faith- 
fully followed that of the protein distribution. Thus, 
while in female controls no periportal mRNA signal, 
and in males only a very weak signal. could be detected 
after hypophysectomy. periportal samples exhibited a 
strong mRNA signal in both sexes (Figs. 2 and 3). In 
congruence with the effect on the CYP2B1/2 protein, 
hypophysectomy not only increased the total expres- 
sion, but also completely abolished the original differ- 
ence between periportal and perivenous mRNA expres- 
sion. 
Hypophysectomized animals were next treated with 
GH to study the direct involvement of this hormone. 
Female hypophysectomized rats that had been treated 
for 7 days with hGH by osmotic infusion exhibited an 
almost completely normalized 2B1/2 distribution (Figs. 
2 and 3). The expression of the CYP2Bl/2 protein in the 
periportal region was extinguished. while the amount of 
protein in the perivenous lysates was only slightly af- 
fected. GH treatment also markedly reduced the peri- 
portal mRNA signal, but did not, however, fully extin- 
guish it. This suggests that GH acted not only at the 
pre-translational level but also at the translational or 
post-translational level. The effects of GH treatment in 
hypophysectomized males were less distinct. GH infu- 
sion reduced the 2B1/2 apoprotein to one-seventh in 
periportal samples, but only to one-half in perivenous 
lysates. This resulted in partial restoration of the nor- 
mal perivenous expression pattern. However, in the hy- 
pophysectomized males, GH did not appear to have a 
zone-specific effect at the mRNA level. Both periportal 
and perivenous CYP2B1/2 mRNA was reduced to 
about one-half and no acinar gradient was established. 
These results provide strong evidence that growth 
hormone represses the expression of CYP2B1/2 in the 
periportal region. The finding that GH treatment coun- 
teracted hypophysectomy more efficiently in females 
than in males could be due to the continuous minipump 
infusion of GH, which mimicks the female GH secretion 
pattern. On the other hand, continuous GH infusion 
has been found to be more efficient than intermittent 
injections in repressing not only CYPZB1/2 [9] but also 
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Fig. t. Effect of hypophys~ct~my on the distribution of the CYPZBlIZ in liver sections. Immunohistochemical staining was performed as described 
in sectton 2. C, control female (left panel); Hx, hypophysectomized female (right panel); cv. central vein area; p, portal vein area. 
several male-specific CYP forms [15,16]. Other pituitary 
regulated factors, such as thyroid hormones and gluco- 
corticoids, also regulate the expression of CYP2Bl/2 
[ 17,187. These factors could play a more prominent roIe 
in males, thus explaining their weaker GH response. 
5! 8 
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Fig. 2. Effect of hypophysectomy and GH treatment on CYP2B1/2 
protein and mRNA in periportal (p) and perivenous (v) cell lysates. 
For immunohlots (upper panel) 60 pg protein was apphed for control 
(C) and hypophysectom~ed + GH-treated rats (Hx + GH) and 30,~g 
for hypophysectomized +salme-treated (Hx + S) rats. For CYP2B112 
mRNA dete~ination lOpI of cDNA produced from total RNA from 
cell lysates was amplified with PCR (lower panel). Boehringer DNA 
molecular weight marker VI was co-electrophoresed. 
Growth hormone could repress gene expression, spe- 
cifically in the periportal region, by several alternative 
mechanisms, all of which would be based upon gradi- 
ents along the portocentral axis in the sinusoid. To our 
knowledge, there is as yet no information on the steep- 
ness of the GH gradient in the liver or on GH receptor 
zonation in the liver. Such gradients have been reported 
for EGF and for several hormones, including insulin, 
glucagon and thyroxine (for a review, see 121). Interest- 
ingly, zonation of the EGF receptor has been described, 
with high expression of high-afinity receptors in peri- 
portal cells 1191. 
The majority of the P450 enzymes, as well as many 
other liver enzymes, share the centrilobular expression 
pattern of the CYPZBIlZ gene pair. We suggest that GH 
is involved in the low or absent expression of some of 
these proteins in the periportal region. In support of this 
suggestion. we recently observed that hypophysectomy 
increases the periportal expression of another gene, car- 
bonic anhydrase II, that is normally found mainly in the 
perivenous region [20] (T. Oinonen and K. Lindros, 
unpublished). On the other hand, GH probably regu- 
lates the expression of other proteins in the opposite 
way, thus allowing or stimulating their expression in the 
periportal region. 
In conclusion, our observation of the GH-induced 
repression of CYP2Blf2 isoenzymes in the periportal 
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Fig. 3. Videodensitometric quantltation of CYP2Bl/? apoprotein and mRNA. The figures are means k S.D. from 4 or 5 pairs of perlportal (p) 
and perivenous (v) eluates from control, hypophysectonuzed (Hx + S) and hypophysectomlzed GH-treated (Hx + GH) female and male rats. 
100% = perlvenous control value *. ** and *** = P < 0.05.0.01 and 0 001. respectively, for statistical significance (Student‘s /-test) of p-vdlfference 
withm each group. b.d, below detection limit. 
region demonstrates that a hormone-mediated signal 
can be restricted to one zone, either allowing or prevent- 
ing the expression of a gene product. We suggest that 
the importance of GH, and probably also of other 
hormones, in zonated liver gene expression has previ- 
ously been underestimated. 
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